Table 4.

Features that were incorporated into the final model and significantly contribute to moderate-to-severe steatosis.

Characteristic	Sa≥S2b	S<S2	P value
Age (≥60 years), n (%)	165/273 (60.4)	291/643 (45.3)	<.001
Education (high), n (%)	25/273 (9.2)	163/643 (25.3)	<.001
Physical activity (moderate), n(%)	45/273 (16.5)	87/643 (13.5)	.25
Alcohol (male; 0), n (%)	117/137 (85.4)	224/306 (73.2)	.007
Smoking (male; ever), n (%)	42/137 (30.7)	71/306 (23.2)	.12
Finance (rich), n (%)	7/273 (2.6)	31/643 (4.8)	.12
Hypertension, n (%)	138/273 (50.5)	259/643 (40.3)	.004
Hyperuricemia, n (%)	20/273 (7.3)	29/643 (4.5)	.08
Diabetes, n (%)	88/273 (32.2)	154/643 (24.0)	.009
Hyperlipemia, n (%)	53/273 (19.4)	83/643 (12.9)	.01
BMI (kg/m2), mean (SD)	26.0 (2.8)	24.1 (3.2)	<.001
Waist circumference (cm), mean (SD)	90.5 (6.6)	82.6 (7.6)	<.001
Fasting plasma glucose (mmol/L), mean (SD)	6.6 (1.8)	5.8 (1.5)	<.001
Postprandial plasma glucose (mmol/L), mean (SD)	10.1 (4.0)	8.4 (2.5)	<.001
Hemoglobin A1c (%), mean (SD)	6.2 (1.4)	5.9 (1.1)	<.001
Total bilirubin (μmol/L), mean (SD)	14.4 (10.0)	12.4 (5.1)	<.001
Uric acid (μmol/L), mean (SD)	351 (87.0)	317 (71.7)	<.001
Triglyceride (mmol/L), mean (SD)	2.0 (1.6)	1.7 (1.3)	.01
High-density lipoprotein-cholesterol (mmol/L), mean (SD)	1.2 (0.3)	1.3 (0.6)	.03
Low-density lipoprotein-cholesterol (mmol/L), mean (SD)	3.0 (0.9)	2.8 (0.9)	.03
Alanine transaminase (U/L), mean (SD)	29.8 (17.4)	26 (13.6)	.005
Aspartate transaminase (U/L), mean (SD)	27.7 (22.1)	25.4 (9.5)	.02
γ-Glutamyl transpeptidase (U/L), mean (SD)	39.1 (32.8)	33 (16.8)	.001
High-sensitivity C-reactive protein (mg/L), mean (SD)	2.7 (2.9)	1.8 (2.3)	<.001
Platelets (× 109/L), mean (SD)	217 (56.5)	209 (53.9)	.03
Hemoglobin (g/L), mean (SD)	139 (28.6)	134 (26.2)	.02

^aS: hepatic steatosis stage.

^bS2: moderate steatosis.